Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement

Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement

Systemic drug therapy remains first-line treatment for primarily disseminated breast cancer (BC). The problem in the use of local methods to treat BC patients with distant metastases has not been fully solved. The most of investigations presented in the modern literature suggest that patients show s...

Full description

Bibliographic Details
Main Authors: Yu. A. Ragulin, G. V. Afonin, G. G. Aminov, A. V. Sidorin
Format: Article
Language:Russian
Published: ABV-press 2016-06-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:
breast cancer stage iv
surgery
radiotherapy
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/478
id doaj-3d0901e50a9448e0a83c51626125f213
record_format Article
spelling doaj-3d0901e50a9448e0a83c51626125f2132021-07-29T08:46:51ZrusABV-pressOpuholi Ženskoj Reproduktivnoj Sistemy1994-40981999-86272016-06-01121636710.17650/1994-4098-2016-12-1-63-67485Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvementYu. A. Ragulin0G. V. Afonin1G. G. Aminov2A. V. Sidorin3A.F. Tsyb Medical Radiology Research Center – Branch of National Medical Radiology Research Center, Ministry of Health of Russia; 4 Koroleva St., Obninsk, Kaluga Region, 249036, RussiaA.F. Tsyb Medical Radiology Research Center – Branch of National Medical Radiology Research Center, Ministry of Health of Russia; 4 Koroleva St., Obninsk, Kaluga Region, 249036, RussiaA.F. Tsyb Medical Radiology Research Center – Branch of National Medical Radiology Research Center, Ministry of Health of Russia; 4 Koroleva St., Obninsk, Kaluga Region, 249036, RussiaA.F. Tsyb Medical Radiology Research Center – Branch of National Medical Radiology Research Center, Ministry of Health of Russia; 4 Koroleva St., Obninsk, Kaluga Region, 249036, RussiaSystemic drug therapy remains first-line treatment for primarily disseminated breast cancer (BC). The problem in the use of local methods to treat BC patients with distant metastases has not been fully solved. The most of investigations presented in the modern literature suggest that patients show significantly better survivals after adjuvant systemic therapy with local exposure of a primary tumor, the main goal of which is its local monitoring. At the same time, the choice of optimal treatments and their sequence and combination remain to be explored. The paper describes a case of successful organ-sparing chemoradiation therapy for primarily disseminated BC with metachronous bilateral involvement.https://ojrs.abvpress.ru/ojrs/article/view/478breast cancer stage ivsurgeryradiotherapy
collection DOAJ
language Russian
format Article
sources DOAJ
author Yu. A. Ragulin
G. V. Afonin
G. G. Aminov
A. V. Sidorin
spellingShingle Yu. A. Ragulin
G. V. Afonin
G. G. Aminov
A. V. Sidorin
Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
Opuholi Ženskoj Reproduktivnoj Sistemy
breast cancer stage iv
surgery
radiotherapy
author_facet Yu. A. Ragulin
G. V. Afonin
G. G. Aminov
A. V. Sidorin
author_sort Yu. A. Ragulin
title Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
title_short Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
title_full Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
title_fullStr Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
title_full_unstemmed Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
title_sort organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
publisher ABV-press
series Opuholi Ženskoj Reproduktivnoj Sistemy
issn 1994-4098
1999-8627
publishDate 2016-06-01
description Systemic drug therapy remains first-line treatment for primarily disseminated breast cancer (BC). The problem in the use of local methods to treat BC patients with distant metastases has not been fully solved. The most of investigations presented in the modern literature suggest that patients show significantly better survivals after adjuvant systemic therapy with local exposure of a primary tumor, the main goal of which is its local monitoring. At the same time, the choice of optimal treatments and their sequence and combination remain to be explored. The paper describes a case of successful organ-sparing chemoradiation therapy for primarily disseminated BC with metachronous bilateral involvement.
topic breast cancer stage iv
surgery
radiotherapy
url https://ojrs.abvpress.ru/ojrs/article/view/478
work_keys_str_mv AT yuaragulin organsparingtreatmentforprimarilydisseminatedbreastcancerwithmetachronousbilateralinvolvement
AT gvafonin organsparingtreatmentforprimarilydisseminatedbreastcancerwithmetachronousbilateralinvolvement
AT ggaminov organsparingtreatmentforprimarilydisseminatedbreastcancerwithmetachronousbilateralinvolvement
AT avsidorin organsparingtreatmentforprimarilydisseminatedbreastcancerwithmetachronousbilateralinvolvement
_version_ 1721251554444443648

Similar Items